review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-5728(99)00084-3 |
P698 | PubMed publication ID | 10430040 |
P2093 | author name string | Lee SJ | |
Benveniste EN | |||
P2860 | cites work | Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation | Q24292971 |
Expression cloning of a functional glycoprotein ligand for P-selectin | Q24304912 | ||
The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor | Q24306681 | ||
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors | Q24669528 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families | Q28114775 | ||
Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis | Q28285576 | ||
TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha | Q28287007 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo | Q30463937 | ||
Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro | Q34237390 | ||
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system | Q34377314 | ||
Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes | Q36232080 | ||
A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule | Q36348294 | ||
An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis | Q36353675 | ||
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma | Q36361169 | ||
CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation | Q36363119 | ||
Microglia induce CD4 T lymphocyte final effector function and death | Q36367580 | ||
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. | Q36537918 | ||
Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease | Q36885953 | ||
Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha | Q37375605 | ||
The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin | Q37388211 | ||
Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes | Q37553147 | ||
Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin | Q38295258 | ||
Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation | Q38334824 | ||
TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence | Q38341183 | ||
VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders | Q38350992 | ||
Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species | Q40401707 | ||
The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion | Q40664863 | ||
Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes | Q41051387 | ||
Clustering the adhesion molecules VLA‐4 (CD49d/CD29) in Jurkat T cells or VCAM‐1 (CD106) in endothelial (ECV 304) cells activates the phosphoinositide pathway and triggers Ca2+ mobilization | Q41107367 | ||
Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils | Q41138980 | ||
The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation | Q41293222 | ||
A novel soluble form of mouse VCAM-1 is generated from a glycolipid-anchored splicing variant | Q41493019 | ||
Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation | Q41503305 | ||
Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. | Q41541656 | ||
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. | Q41743693 | ||
Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC | Q41958843 | ||
Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines | Q42453393 | ||
Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-kappaB and C/EBP isoforms | Q42466928 | ||
CD2-mediated adhesion facilitates T lymphocyte antigen recognition function | Q44684718 | ||
Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis | Q45765166 | ||
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. | Q46007698 | ||
Mature microglia resemble immature antigen-presenting cells | Q46471783 | ||
Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α | Q46904341 | ||
Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis | Q47964562 | ||
Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. | Q48245976 | ||
Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. | Q48328310 | ||
Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system | Q48494253 | ||
Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging | Q48695953 | ||
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b | Q48718477 | ||
Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI. | Q48718633 | ||
Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells | Q48753174 | ||
Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis | Q48789234 | ||
Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line. The activation of Lyn tyrosine kinase and the mitogen-activated protein kinase pathway | Q57042907 | ||
Interleukin 1-β- and tumor necrosis factor-α-mediated regulation of ICAM-1 gene expression in astrocytes requires protein kinase C activity | Q60178459 | ||
Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders | Q64410758 | ||
Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells | Q67542877 | ||
A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-alpha, interferon-gamma and interleukin 1 | Q68164618 | ||
Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1 | Q71081998 | ||
Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis | Q71623377 | ||
Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis | Q71650901 | ||
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse | Q71661620 | ||
Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity | Q71667770 | ||
The adhesion molecule and cytokine profile of multiple sclerosis lesions | Q71688111 | ||
Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging | Q71707551 | ||
Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines | Q72132467 | ||
Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system | Q72319828 | ||
Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis | Q72643563 | ||
Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis | Q72657582 | ||
Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus | Q72681433 | ||
VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta | Q73809906 | ||
Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease | Q74429476 | ||
Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis | Q77180200 | ||
Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells | Q77450629 | ||
P433 | issue | 2 | |
P921 | main subject | nervous system | Q9404 |
P304 | page(s) | 77-88 | |
P577 | publication date | 1999-08-01 | |
P1433 | published in | Journal of Neuroimmunology | Q15716691 |
P1476 | title | Adhesion molecule expression and regulation on cells of the central nervous system | |
P478 | volume | 98 |
Q36865438 | 15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases |
Q39866917 | A comparative evaluation of the response to peroxynitrite by a brain endothelial cell line and control of the effects by drug targeting |
Q35088195 | A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. |
Q48559501 | Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development |
Q28583914 | Adhesion molecule expression in experimental myositis |
Q38265637 | Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis |
Q81003728 | Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice |
Q64110856 | Astrocyte Mechano-Activation by High-Rate Overpressure Involves Alterations in Structural and Junctional Proteins |
Q25255834 | Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. |
Q73847263 | Beneficial effect of orally administered myelin basic protein in EAE-susceptible Lewis rats in a model of acute CNS degeneration |
Q48522237 | Beta-amyloid-associated expression of intercellular adhesion molecule-1 in brain cortical tissue of transgenic Tg2576 mice |
Q58697672 | CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease |
Q38583607 | CXCL12/CXCR4 axis: an emerging neuromodulator in pathological pain |
Q57456677 | Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism |
Q92489450 | Cell adhesion molecules in Alzheimer's disease |
Q36251782 | Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis |
Q27313520 | Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4. |
Q35224084 | Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice |
Q46767693 | Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis |
Q74228648 | Cobalamin (vitamin B(12)) positively regulates interleukin-6 levels in rat cerebrospinal fluid |
Q48672172 | Concentration of soluble adhesion molecules in cerebrospinal fluid and serum of epilepsy patients |
Q30483239 | Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction |
Q37127109 | Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis |
Q45448838 | Differential astrocyte response to Theiler's murine encephalomyelitis virus infection |
Q51586474 | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. |
Q46844281 | Differential regulation of c-Jun N-terminal kinase and NF-kappaB pathway by caffeic acid phenethyl ester in astroglial and monocytic cells |
Q37471968 | Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing |
Q47112591 | Distinct cytokine patterns may regulate the severity of neonatal asphyxia-an observational study. |
Q34064027 | Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex |
Q44969003 | Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. |
Q37569879 | Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia |
Q44480144 | Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobe |
Q58027562 | Effect of astrocyte-targeted production of IL-6 on traumatic brain injury and its impact on the cortical transcriptome |
Q50210143 | Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder. |
Q46658971 | Endothelial activation and chemoattractant expression are early processes in isolated blast brain injury. |
Q79195309 | Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex |
Q48228365 | Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro |
Q78652323 | Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis |
Q28213577 | Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis |
Q34508369 | Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system |
Q34771671 | Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions? |
Q40223830 | GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions |
Q37117548 | Genetic factors influencing alcohol dependence |
Q37111630 | Glial connexins and gap junctions in CNS inflammation and disease |
Q36026673 | Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury |
Q40227861 | Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation |
Q57925075 | Hypertension Increases Retinal Inflammation in Experimental Diabetes: A Possible Mechanism for Aggravation of Diabetic Retinopathy by Hypertension |
Q58768157 | Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels |
Q34418742 | ICAM-1: isoforms and phenotypes |
Q42639860 | Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation |
Q28733365 | Immune Regulation of Antibody Access to Neuronal Tissues |
Q34094707 | Immune function of microglia |
Q87727076 | In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis |
Q48422331 | Increase in adhesion molecules in cerebrospinal fluid of children with mumps and mumps meningitis. |
Q31002573 | Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice |
Q40616738 | Induction of intercellular adhesion molecule-1 by Fas ligation: proinflammatory roles of Fas in human astroglioma cells |
Q48253153 | Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat. |
Q44692991 | Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation |
Q73449246 | Intrathecal release of sICAM-1 into CSF in neuroborreliosis--increased brain-derived fraction |
Q33776820 | Kv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in experimental autoimmune encephalomyelitis |
Q33572850 | Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies |
Q35569335 | Lactosylceramide Mediates the Expression of Adhesion Molecules in TNF-α and IFNγ-stimulated Primary Cultured Astrocytes |
Q30437758 | Leukocyte adhesion molecules in animal models of inflammatory bowel disease |
Q37188711 | Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease |
Q36991987 | Longitudinal brain structural alterations and systemic inflammation in obstructive sleep apnea before and after surgical treatment |
Q37777780 | Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches |
Q37960903 | Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis |
Q57109819 | Malignant invasion of the central nervous system: the hidden face of a poorly understood outcome of prostate cancer |
Q64229784 | Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis |
Q34247703 | Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis |
Q35581623 | Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification |
Q37333298 | Microglia: gatekeepers of central nervous system immunology. |
Q33850754 | Molecular pathogenesis of multiple sclerosis |
Q36322783 | Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. |
Q36581622 | Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening. |
Q35208773 | Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis |
Q36284072 | Natalizumab for the treatment of multiple sclerosis and Crohn's disease |
Q35894949 | Neurolymphomatosis |
Q35048837 | New models of intravital microscopy for analysis of chemokine receptor-mediated leukocyte vascular recognition |
Q34784409 | Noradrenergic regulation of inflammatory gene expression in brain. |
Q46808090 | Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals |
Q34614995 | Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study |
Q54144878 | Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome. |
Q33641789 | Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients |
Q85266058 | Psoriasis during natalizumab treatment for multiple sclerosis |
Q74448866 | RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes |
Q35118708 | Rapid identification of fluorochrome modification sites in proteins by LC ESI-Q-TOF mass spectrometry |
Q78952388 | Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2 |
Q38082722 | Regulation and dysregulation of astrocyte activation and implications in tumor formation |
Q45023548 | Regulation of the hyperpolarization-activated cationic current Ih in mouse hippocampal pyramidal neurones by vitronectin, a component of extracellular matrix |
Q79253316 | Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+regulatory T cells |
Q38159803 | Selectins and their ligands as potential immunotherapeutic targets in neurological diseases |
Q42502169 | Sequential upregulation of cell adhesion molecules in degenerating rat basal forebrain cholinergic neurons and in phagocytotic microglial cells |
Q41501738 | Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder. |
Q36712231 | Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia |
Q35537898 | Statins and their potential targets in multiple sclerosis therapy |
Q35753051 | Statins as potential therapeutic agents in multiple sclerosis |
Q34120877 | Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock |
Q48931522 | T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells |
Q58199700 | TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis |
Q52668332 | The Role of Astrocytes in Multiple Sclerosis. |
Q91867232 | The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders |
Q34623345 | The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study |
Q78966702 | The expression of adhesion molecules in muscle biopsies: the LFA-1/VLA-4 ratio in polymyositis |
Q29620066 | The immunology of stroke: from mechanisms to translation |
Q39027973 | The reciprocal interactions between astrocytes and prostate cancer cells represent an early event associated with brain metastasis |
Q37479890 | The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies. |
Q31132948 | The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). |
Q42514543 | Time course of VCAM-1 and ICAM-1 in CSF in patients with basal ganglia haemorrhage |
Q39906493 | Tong Luo Jiu Nao, a Chinese Medicine Formula, Reduces Inflammatory Stress in a Mouse Model of Alzheimer's Disease |
Q36376697 | Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. |
Q26830912 | Traumatic brain injury, neuroinflammation, and post-traumatic headaches |
Q43572623 | Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model |
Q37424337 | Ultrasound molecular imaging |
Q35001301 | Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes. |
Q36518182 | Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC |
Q35109268 | Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes |
Q35104910 | White matter damage and systemic inflammation in obstructive sleep apnea |
Q64923680 | [Blocking adhesion molecules with natalizumab in multiple sclerosis]. |
Q81778491 | [Possible target specific molecular imaging with ultrasound contrast agents] |
Search more.